Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 890 (2021-2022)

SB 890 is a bill of the Michigan Legislature, 2021-2022 session, in committee as of 2022-02-24; sponsored by Dayna Polehanki and 10 others.

https://ontology.bommaritollc.com/id/01a0d568-6cdb-72f2-acfb-732ccc7ac198

Cite this

SB 890 (2021-2022). bc-ontology, release 0.1.0-rc15, 2026-09-28. https://ontology.bommaritollc.com/id/01a0d568-6cdb-72f2-acfb-732ccc7ac198

Elsewhere

Official pagewww.legislature.mi.gov

adms:identifier	mi-legislature-measure 2021-2022/SB/890
dcterms:temporal	Michigan Legislature, 2021-2022 session
primary sponsor	Dayna Polehanki
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-0890 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-0890 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-0890
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	SB 890
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; certain licensing fees for drug manufacturers; modify for certain purposes. Amends secs. 16315, 16319 & 16333 of 1978 PA 368 (MCL 333.16315 et seq.).en
schema:sponsor	Erika Geiss Stephanie Chang Dayna Polehanki Jeremy Moss Mallory McMorrow Paul Wojno Rosemary Bayer Jeff Irwin Winnie Brinks Marshall Bullock II Jim Ananich
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-0890
skos:prefLabel	SB 890 (2021-2022)en
status	in committee
status date	2022-02-24xsd:date